Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Added to Bupivacaine in ESP Block for Pediatric Lower Abdominal Surgery
NCT07023991Phase 1Enrolling by invitation
- Sponsor
- Ain Shams University
- Start
- May 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Ain Shams University. Primary endpoint: Duration of Postoperative Analgesia up to 24 hours. Started May 2025; status: enrolling by invitation.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07023991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07023991.